| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
The molecular sources of reactive oxygen species (ROS) in skeletal
muscles are not well understood. We hypothesized that nonphagocyte NAD(P)H oxidase could be a source of ROS in muscle fibers.
We thus investigated the existence, structure, and contribution of nonphagocyte NAD(P)H oxidase to ROS production in rat skeletal muscles. ROS production and NAD(P)H oxidase activity were evaluated by lucigenin-enhanced chemiluminescence and NADH consumption rate, whereas enzyme composition was monitored by reverse transcription-polymerase chain reaction and immunoblotting.
Basal O2
production in muscle strips from normal rats averaged
1.4 nmol/mg per 10 min and increased to ~ 18 nmol/mg per 10 min in the presence of NADH. Muscle O2
production and NADH
consumption were inhibited by Tiron, superoxide dismutase, apocynin, and diphenyleneiodonium but not by inhibitors of cyclo-oxygenases, xanthine oxidase, nitric oxide synthases (NOS), and mitochondrial enzymes. We detected mRNA and proteins of p22phox,
gp91phox, p47phox, and p67phox subunits in normal rat muscles. These
subunits were localized in close proximity to the sarcolemma. Induction of sepsis in rats doubled muscle O2
production with no
major changes in muscle NADPH oxide subunit expression. In lipopolysaccharide-treated but not in control muscles, O2
production was increased significantly by NOS inhibition. We conclude
that a constitutively active NAD(P)H oxidase enzyme complex exists in normal skeletal muscle fibers and contributes to ROS production. In septic rats, this production is increased but measurable O2
is reduced by enhanced NO production.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: NADPH oxidase; nitric oxide; oxygen radicals; sepsis; skeletal muscle
Reactive oxygen species (ROS) in general and superoxide anions (O2
) in particular are produced inside skeletal muscle fibers
under normal and pathological conditions (1, 2). In resting
skeletal muscles, O2
radicals are released into the extracellular
space at relatively low rates, and the rate of O2
production
rises significantly in response to increased muscle activity (3, 4).
Many cellular sources are involved in the production of ROS,
including NAD(P)H-dependent electron transport chains, membrane-bound oxidoreductases, cytosolic xanthine oxidase, and
the cyclo-oxygenase pathway of arachidonic acid metabolism. The contribution of these sources to O2
production has been
investigated mainly in lung tissue, hepatic tissues, endothelial
cells, and vascular smooth muscles, but the exact involvement of
these sources in ROS production inside skeletal muscle fibers
remains unclear. Studies suggest that a significant portion of
ROS production in response to increased muscle activity is
not derived from the mitochondria and is dependent on the
presence of NAD(P)H (5). These results suggest that a nonmitochondrial oxidase, which uses NADPH, exists in skeletal muscles and increases its production of ROS in response to increased
muscle activity.
NAD(P)H oxidase, which catalyzes the production of O2
by
one-electron reduction of O2, using NADPH or NADH as the
electron donor, exists both in phagocytes (6) and in nonphagocytes such as fibroblasts, chondrocytes, and mesangial, microglial, epithelial, endothelial, and vascular smooth muscle cells (for
review, see Reference 7). Significant differences have emerged
between phagocytic and nonphagocytic NAD(P)H oxidases such
as those concerning subunit structure, substrate preference, and
time course of activity (7). Despite progress in the characterization of NAD(P)H oxidase in vascular and mesangial cells, no
information is yet available regarding the existence, subunit
structure, localization, and contribution of this enzyme system
to the production of O2
in skeletal muscle fibers.
Nitric oxide (NO) is normally synthesized inside skeletal
muscle fibers by the neuronal (nNOS) and endothelial (ecNOS) nitric oxide synthases (8, 9). Accumulating evidence indicates that NO modulates intracellular ROS levels in vascular
cells through a direct interaction with O2
and indirectly
through its effect on enzymatic activities responsible for ROS
production, such as that of NAD(P)H oxidase and xanthine oxidase (10, 11). Despite the presence of abundant NOS proteins inside skeletal muscle fibers, little is known about the influence of NO on O2
production in these fibers.
We hypothesized in this study that NAD(P)H oxidase exists
inside skeletal muscle fibers and contributes to the production of ROS inside these fibers. To test this hypothesis, we studied subunit composition, localization, and substrate use of the
NAD(P)H oxidase enzyme complex system in normal skeletal
muscles. We also measured the contribution of NAD(P)H oxidase to skeletal muscle ROS production under normal conditions and in response to severe sepsis. Finally, we investigated
whether constitutive NO release inside muscle fibers influences
the production of O2
by muscle NAD(P)H oxidase.
| |
METHODS |
|---|
|
|
|---|
More details are provided in the online data supplement.
General Animal Preparation
Adult male Sprague-Dawley rats were killed with an overdose of pentobarbital sodium and the diaphragm and limb muscles were either
excised and frozen in liquid nitrogen or embedded in Histo Prep medium, frozen in cooled isopentane, and then stored at
80° C. In a few
experiments, muscles were removed and quickly placed in ice-cold
Krebs-HEPES buffer, and then radial strips were excised from each
muscle and placed in the same buffer for a period of 30 min.
Induction of Sepsis
Two groups (n = 6 in each group) of male rats were examined 18 h after intraperitoneal injection of either normal saline (control group) or Escherichia coli lipopolysaccharide (LPS, serotype 055:B5; 10-12 mg/kg) (septic group). We also examined five groups (n = 6 in each group) of rats, which were killed 1, 3, 6, 12, and 24 h after LPS injection and from which the diaphragms were collected as mentioned above.
Preparation of Muscle Fractions
Separation of mitochondrial, membrane, and cytosolic muscle fractions was performed as described by Rock and coworkers (12). In brief, crude muscle homogenates were prepared by homogenization in a specific buffer (12) and were then centrifuged at 1,000 × g. The mitochondrial fraction was collected from crude homogenates by centrifugation at 12,000 × g. The resulting supernatants then underwent centrifugation at 37,500 × g, yielding supernatants (cytosolic fraction) and pellets (membrane fraction). The Bradford method (Bio-Rad, Hercules, CA) was used to measure protein levels in all muscle fractions.
Measurement of O2
Radicals by
Lucigenin-Derived Chemiluminescence
Increasing xanthine levels were incubated with cytochrome c (80 µM)
and 8 units of xanthine oxidase at 37° C in the presence and absence of
superoxide dismutase (SOD) (1.5 U/ml). Absorbance at 550 nm was
measured with a spectrophotometer and the levels of O2
produced
were calculated as described previously (13). The amount of O2
calculated was then used to calibrate lucigenin-derived cheniluminescence (LDCL) signal obtained by mixing the same levels of xanthine and xanthine oxidase in a luminometer (Lumat LB 9501; Berthold, Pforzheim, Germany). For measurement of O2
in muscle samples, muscles were
heated in a water bath to 37° C and lucigenin (230 µM) was then added
to the tube, which was then immediately placed inside the luminometer.
Luminometer output was measured for a 10-min period. Muscle LDCL
was measured in the presence of lucigenin alone (basal), NADH (100 µM), and NADPH (100 µM). Additional groups of diaphragmatic muscle strips were preincubated for 20 min at 37° C with Tiron (10 mM),
diphenyleneiodonium (DPI, 1.85 µM), SOD (0.5 U/ml), NG-nitro-
L-arginine methyl ester (L-NAME, 1 mM), oxypurinol (300 µM), indomethacin (100 µM), and rotenone (250 µM). Basal and NADH-stimulated LDCL signals were then measured as mentioned above.
Measurement of NADH Consumption
Aliquots of muscle fractions (12.5 to 100 µg of total proteins) were incubated with NADH (100 µM) at 37° C in the absence and presence
of the above-mentioned antioxidants and inhibitors of ROS-generating enzymes and the rate of NADH consumption was monitored by
measuring the decline in absorbance at
= 340 nm.
Reverse Transcription-Polymerase Chain Reaction
Muscle total RNA (1 µg) was reverse transcribed with random hexamers and Moloney murine leukemia virus (Mo-MuLV) reverse transcriptase (RT). Rat-specific NADH oxidase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs were then amplified by polymerase chain reaction (PCR) using specific oligonucleotide primers (Table 1). Ethidium bromide-stained 2% agarose gels and an optical density scanner were used to separate, visualize, and quantify the intensity of PCR products.
|
Immunoblotting
Muscle fractions (80 µg per sample) were mixed with sample buffer, boiled, loaded onto Tris-glycine sodium dodecyl sulfate (SDS) polyacrylamide gels, and separated by electrophoresis. Lysates of human and rat neutrophils were used as positive controls. Proteins were transferred electrophoretically to polyvinylidene difluoride (PVDF) membranes, blocked with nonfat dry milk, and then incubated with two sets of primary monoclonal or polyclonal anti-human NAD(P)H oxidase antibodies (14). Membranes were then washed and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies. Specific proteins were detected with a chemiluminescence kit.
Immunohistochemistry
Frozen tissue sections were fixed with acetone, rehydrated with phosphate-buffered saline (PBS), blocked with normal donkey serum, and then incubated overnight with anti-human NAD(P)H oxidase antibodies. For negative control, primary antibodies were replaced with nonspecific mouse or rabbit IgGs. After three rinses with PBS, sections were incubated with Cy3-labeled anti-mouse or anti-rabbit secondary antibodies, washed, mounted with coverslips, and examined with a fluorescence microscope.
Statistical Analysis
Values are presented as means ± SEM. Differences in O2
production, protein optical densities, and rate of NADH use were detected by one-way analysis of variance (ANOVA) followed by the Tukey test for multiple comparisons. Linear regression analysis was used to
quantify the rate of NADH consumption in the absence and presence
of various inhibitors.
| |
RESULTS |
|---|
|
|
|---|
Production of O2
Radicals in Normal Skeletal Muscles
Luminometer output was linearly related to the amount of
xanthine used during the production of the calibration curve
(ranging between 1 and 64 nmol) (r = 0.99; Figure 1A). The
addition of SOD resulted in a signal that was not different
from background, confirming that O2
radicals are responsible
for the luminescence. Figure 1B shows representative LDCL signals obtained from normal rat diaphragms. LDCL signals were
significantly higher in the presence of NADH than under basal
conditions or in the presence of NADPH (Figure 1B). Figure 2
shows mean values of O2
radicals produced by normal rat diaphragms. Muscle O2
levels were significantly higher in the
presence of NADH compared with basal levels and those measured in the presence of NADPH (Figure 2A). Basal O2
levels
were significantly attenuated by SOD, DPI, Tiron, and oxypurinol
(p < 0.05), whereas L-NAME, indomethacin, and rotenone were
without any significant effects on basal O2
levels (Figure 2B).
Similarly, NADH-enhanced O2
radical production was significantly reduced by SOD, DPI, and Tiron but not by L-NAME,
oxypurinol (Figure 2C), and rotenone (not shown). The observation that DPI inhibited both basal and NADH-dependent
O2
production, whereas only the basal O2
level was attenuated by oxypurinol, suggests that both xanthine oxidase and
NAD(P)H oxidase contribute to basal ROS production, whereas NAD(P)H oxidase is the main source of NADH-stimulated ROS production in normal muscle fibers. A similar
preference of muscle O2
production for NADH was also
found in the soleus and gastrocnemius muscles (Figure 3).
|
|
|
NADH Consumption
No significant NADH consumption was detected in cytosolic muscle fractions even at protein aliquots exceeding 100 µg. By comparison, NADH consumption by the membrane fraction rose linearly with respect to time at protein levels of 12.5 and 25 µg (Figure 4A). However, at 50 and 100 µg, NADH consumption peaked within 40 and 10 min, respectively (Figure 4A). As shown in Figure 4B, the rate of NADH consumption by the membrane fraction of normal rat diaphragm rose linearly with sample protein concentration (r = 0.95, p < 0.001). The NADH consumption rate (measured at the 50-µg total protein level over a 40-min period) of the diaphragmatic membrane fraction was significantly inhibited by apocynin and DPI (p < 0.05 and p < 0.01, respectively) but not by indomethacin, oxypurinol, rotenone, or L-NAME (Figure 5).
|
|
NAD(P)H Oxidase Subunit Structure and Localization
We detected mRNA transcripts of p22phox, gp91phox, p47phox, and p67phox subunits of phagocyte NADPH oxidase in diaphragmatic and gastrocnemius samples, using RT-PCR (Figure 6). The sequences of partial cDNAs of muscle p22phox and gp91phox were identical to those found in other rat organs (17, 18). We also found that partial cDNAs of muscle p47phox and p67phox subunits have relatively higher homology with mouse neutrophil sequences than with human sequences (Appendices 1 and 2; see online data supplement). In addition to mRNA transcripts, we were able to detect p22phox, gp91phox, p47phox (Figure 7A), and p67phox proteins in normal rat muscles. Interestingly, muscle p22phox protein had an apparent mass of about 30 kDa, which is larger than reported for neutrophil NADPH oxidase subunit. This difference is not related to species differences between humans and rats because the anti-p22phox antibodies detected a 22-kDa protein in rat neutrophil lysate (not shown). Muscle p22phox protein is localized in the membranous rather than in the mitochondrial and cytosolic fractions (Figure 7B). Similarly, we detected gp91phox and p47phox proteins in the membranous fraction of muscle homogenates (results are not shown). We were unable to detect p40phox protein in muscle samples despite the use of two separate monoclonal antibodies. Abundant positive p22phox immunostaining was detected inside skeletal muscle fibers in close proximity to the sarcolemma (Figure 8, top). Nerve fibers did not positively stain with anti-p22phox antibodies. Similar patterns of muscle fiber- and blood vessel-specific immunoreactivity were detected with anti-gp91phox, p47phox, and p67phox antibodies (Figure 8). Positive p40phox immunoreactivity was detectable only in blood vessels traversing muscle fibers. Negative control samples showed no prominent positive immunoreactivity.
|
|
|
Effects of Sepsis on Muscle NAD(P)H Oxidase and O2
Production
No significant alterations in protein expression of p22phox,
gp91phox, and p47phox subunits were observed up to 24 h after
LPS injection, whereas p67phox subunit expression rose significantly higher than control values only after 24 h of LPS injection (Figure 9A). Basal diaphragmatic O2
levels (measured
after 18 h of experimental period) were significantly higher in
the LPS group compared with control muscles (p < 0.05; Figure 9B), whereas NADH-induced O2
production was similar
in the two groups (Figure 9B). However, whereas L-NAME
had no effects on NADH-stimulated O2
production in control
diaphragm, L-NAME significantly elevated NADH-induced
O2
production in septic diaphragms (p < 0.05 compared with
NADH alone) (Figure 9B).
|
| |
DISCUSSION |
|---|
|
|
|---|
The main findings of this study are that (1) a nonmitochondrial NAD(P)H oxidase enzyme complex exists in human and
rat skeletal muscle fibers; (2) this enzyme complex is localized
in close proximity to the sarcolemma and consists of at least
four subunits (p22phox, gp91phox, p47phox, and p67phox); (3) muscle NAD(P)H oxidase prefers NADH as a substrate and contributes in large part to basal O2
production in normal muscle fibers; (4) sepsis is associated with increased muscle O2
production but little change in muscle NAD(P)H oxidase expression; and finally, (5) NO synthesis inside skeletal muscle
fibers exerts an inhibitory effect on muscle O2
levels in sepsis, but not under normal conditions.
Methodological Considerations
The use of LDCL as an accurate method to measure O2
radicals in biological systems has been challenged on the basis that
redox recycling of lucigenin itself may actually produce O2
radicals (19). We believe that redox recycling of lucigenin is
not a major component of LDCL signals observed in our
study for the following reasons: (1) The accuracy of LDCL in
measuring O2
radicals generated by several enzyme systems
has been confirmed, using cytochrome c reduction and electron spin resonance (EPR) (20). We also found a linear relationship between LDCL and cytochrome c reduction in the
presence of xanthine-xanthine oxidase (Figure 1); (2) production of O2
by vascular NAD(P)H oxidases remained largely
unchanged when the lucigenin concentration was elevated from
5 to 250 µM (21); (3) evaluation of O2
production by vascular
NAD(P)H oxidases, using 2-methyl-6-phenyl-3,7-dihydroimidazol[1,2-
]pyrazine-3-one (CLA), which does not undergo
redox recycling, yielded values similar to those measured with
LDCL (22); and (4 ) our evaluation of muscle NAD(P)H oxidase activity was based on two methods, LDCL and NADH
consumption measurements. Furthermore, our proposal that NAD(P)H oxidase exists in skeletal muscle fibers is supported by the observation that DPI exerts similar qualitative effects on both LDCL and NADH consumption measurements (Figures 2 and 5).
NAD(P)H Oxidase in Nonphagocytes
NAD(P)H oxidases are membrane-associated enzymes, which
catalyze the one-electron reduction of molecular O2 using either NADH or NADPH as electron donors. Many structural
and functional differences exist between phagocyte and nonphagocyte NAD(P)H oxidases including differences in orientation of the enzyme system, direction of O2
production, the
rate and time course of O2
production, and subunit composition (7). In phagocytes, NADPH oxidase consists of five components: a plasma membrane-spanning cytochrome b558 (p22phox
and gp91phox) and three cytosolic components (p47phox,
p67phox, and p40phox), which associate with the cytochrome b558
on activation of phagocytes. Other proteins, including Rac2
and Rap1A, may also be involved in the assembly of phagocyte
NADPH oxidase (6). The assembled oxidase complex in phagocytes spans the membrane and utilizes intracellular NADPH or
NADH to transfer electrons to extracellular O2, resulting in
extracellular release of O2
radicals. In nonphagocytes,
mRNA of p22phox, gp91phox, p47phox, and p67phox subunits was
found in endothelial and adventitial cells, whereas only p22phox
and p47phox, not gp91phox, proteins were detected in vascular
smooth muscles and mesangial cells (for review, see Reference
7). It has also been established that an NAD(P)H oxidase enzyme is responsible for extracellular release of O2
radicals in
endothelial cells and fibroblasts, whereas intracellular O2
production has been attributed to NAD(P)H oxidase activity
of vascular smooth muscles (23, 24).
We detected p22phox, gp91phox, p67phox, and p47phox mRNA and proteins in skeletal muscle fibers, whereas p40phox protein was localized in the blood vessels (Figure 8). Our study also indicates that, unlike phagocyte NADPH oxidase, all of the four subunits of muscle-specific NAD(P)H oxidase are constitutively associated with cell membranes, because none of these subunits were detected in the cytosolic fraction. The notion of a membrane-associated muscle-specific NAD(P)H oxidase is also confirmed by histochemical analysis using various antibodies (Figure 8) and by the observation that the muscle membrane fraction, rather than the cytosolic fraction, is largely responsible for NADH consumption. To our knowledge, our study is the first to document the presence of both mRNA and proteins of the four subunits of NAD(P)H oxidase in nonphagocytes. Of interest, we found that the muscle-specific p22phox subunit is larger (30 kDa) than that of phagocyte NADPH oxidase (22 kDa), an observation that could not be explained by species differences because anti-p22phox antibodies detected a 22-kDa protein in rat neutrophils (results are not shown). This observation and the finding that a 30-kDa p22phox subunit is present in sheep microglial cells (25) suggest that specialized forms of NAD(P)H oxidase proteins may be found in various nonphagocyte tissues.
We attempted to evaluate the contribution of NAPDH oxidase to ROS production in skeletal muscle fibers by measuring both the rate of production of O2
radicals and the rate of
NADH consumption in the absence and presence of inhibitors
of various ROS-producing enzymes. The fact that DPI and
apocynin, but not rotenone, L-NAME, or indomethacin, inhibited LDCL signals and NADH consumption confirms that
NAD(P)H oxidase, rather than mitochondrial enzymes, NOS,
or cyclo-oxygenase, is largely responsible for O2
production
and NADH use by the muscle membrane fraction. Moreover, the observation that NADH-induced O2
production was more
effectively inhibited by cell membrane-permeable Tiron than
cell membrane-impermeable SOD (Figure 2C) suggests that a
significant proportion of O2
radicals synthesized by muscle
NAD(P)H oxidase resides intracellularly. We should emphasize in this respect that lucigenin is capable of passing through
cell membranes and can be used to detect intracellular O2
production (26).
Production of O2
Radicals in Sepsis
It is well established that sepsis causes oxidative stress in skeletal
muscle fibers as a result of both an increase in ROS production
and a significant decline in the antioxidant capacity of these
muscles (27). Our results indicate that basal O2
radical
production in the diaphragm of septic rats was significantly higher than that of control animals, confirming that ROS production rises in septic muscles. The molecular sources responsible
for the sepsis-induced rise in ROS production remain under investigation. In the vascular system, sepsis or proinflammatory
cytokines elicit upregulation of p22phox, gp91phox, and p67phox
subunit expression (30, 31). It has also been reported that O2
production by vascular smooth muscle NAD(P)H oxidase increases significantly within minutes of exposure to tumor necrosis
factor
(TNF-
), suggesting that augmentation of NAD(P)H
expression might not be necessary for increased activity of this
enzyme (31). We speculate that NADPH oxidase contributes
significantly to the rise in diaphragmatic O2
production in
septic rats and that increased activity of this enzyme in septic
muscles is mediated through multiple mechanisms including
upregulation of subunit expression, especially that of the p67phox
subunit, as well as posttranslational modifications involving subunit assembly and phosphorylation of specific subunits. Clearly, more research is needed to elucidate the mechanisms through
which sepsis influences NAD(P)H oxidase activation.
Our finding of a significant elevation of NADH-stimulated
O2
radical production in septic muscles when NOS activity
was inhibited suggests that the production of NO can modulate muscle O2
radical production. In normal muscle fibers,
NO is synthesized mainly by the constitutive NOS isoforms (8, 9).
However, in septic animals, larger quantities of NO are synthesized inside skeletal muscle fibers by the inducible (iNOS) isoform of NOS (32). It is, therefore, likely that induction of iNOS
expression and enhanced NO production in septic muscles
might have masked the increase in O2
production in these
muscles. There are two main mechanisms through which NO
influences muscle NAD(P)H oxidase activity: (1) NO can directly react with O2
in a diffusion-limited reaction to produce
peroxynitrite (33). Although earlier reports suggest that peroxynitrite formation is limited to pathological conditions such
as severe sepsis (33), more recent studies indicate the reaction
between NO originating from endothelial cells and O2
generated by nonphagocyte NAD(P)H oxidase in adventitial cells occurs even in normal blood vessels (34); and (2) NO is capable of inhibiting the assembly of cytosolic and membrane-bound
subunits of phagocyte NADPH oxidase radicals (11). Whether
the assembly of muscle NAD(P)H oxidase is also inhibited by
NO remains to be determined. We speculate that this inhibitory
effect of NO on O2
levels in septic muscle could be partly responsible for the protective roles of NOS activity in attenuating
sepsis-induced ventilatory muscle contractile dysfunction (35).
In summary, our study indicates the presence of an NAD(P)H oxidase enzyme complex inside skeletal muscle fiber, which consists of at least four subunits (p22phox, gp91phox, p67phox, and p47phox) and has characteristics that are similar to those of nonphagocyte NAD(P)H oxidases in other tissues. This NAD(P)H oxidase enzyme complex is constitutively active and contributes significantly to basal ROS production inside skeletal muscle fibers under normal conditions and in response to sepsis.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to S. Hussain, M.D., Room L3.05, Critical Care Division, Royal Victoria Hospital, 687 Pine Ave. West, Montreal, Quebec, Canada H3A 1A1. E-mail: sabah.hussain{at}muhc.mcgill.ca
(Received in original form March 8, 2001 and accepted in revised form October 18, 2001).
Funded by grants from the Canadian Institute of Health Research and National Institutes of Health (R01 HL66757 and AR42426).Acknowledgments: The authors are grateful to Ms. J. Nicolac and Mr. L. Franchi for technical expertise and to Ms. C. Mutter for editorial expertise.
| |
References |
|---|
|
|
|---|
1.
Reid MB,
Shoji T,
Moody MR,
Entman ML.
Reactive oxygen in skeletal
muscle. II. Extracellular release of free radicals.
J Appl Physiol
1992;
73:
1805-1809
2.
Reid MB,
Khawli FA,
Moody MR.
Reactive oxygen in skeletal muscle. III.
Contractility of unfatigued muscle.
J Appl Physiol
1993;
75:
1081-1087
3.
Borzone G,
Zhao B,
Merola AJ,
Berliner L,
Clanton TL.
Detection of
free radicals by electron spin resonance in rat diaphragm after resistive loading.
J Appl Physiol
1994;
77:
812-818
4.
Diaz P,
She ZW,
Davis WB,
Clanton TL.
Direct evidence for hydroxyl radical production during diaphragm fatigue.
J Appl Physiol
1993;
75:
540-545
5.
Bejma J,
Ji LL.
Aging and acute exercise enhance free radical generation in rat skeletal muscle.
J Appl Physiol
1999;
87:
465-470
6. DeLeo FR, Quinn MT. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol 1996; 60: 677-691 [Abstract].
7.
Griendling KK,
Sorescu D,
Ushio-Fukai M.
NAD(P)H oxidase. Role in
cardiovascular biology and disease.
Cir Res
2000;
86:
494-501
8. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 1994; 372: 546-548 [Medline].
9. Kobzik L, Stringer B, Balligand JL, Reid MB, Stamler JS. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationship. Biochem Biophys Res Commun 1995; 11: 375-381 .
10.
Ichimori K,
Fukahori M,
Nakazawa H,
Okamoto K,
Nishino T.
Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide.
J Biol Chem
1999;
274:
7763-7768
11.
Fujii H,
Ichimori Y,
Hoshiai K,
Nakazawa H.
Nitric oxide inactivates
NADPH oxidase in pig neutrophils by inhibiting its assembling process.
J Biol Chem
1997;
272:
32773-32778
12. Rock E, Napias C, Sarger C, Chevallier J. Simultaneous preparation of membrane fractions from small amounts of skeletal muscle: a study on mitochondrial fractions from MedJ mice. Biochem Biophys Res Commun 1985; 128: 113-119 [Medline].
13. O'hara Y, Peterson TE, Harrison DG. Hypercholesterolaemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551 .
14. Quinn MT, Parkos CA, Walker L, Orkin SH, Dinauer M, Jesaitis AJ. Association of a Ras-related protein with cytochrome b of human neutrophils. Nature 1989; 342: 198-200 [Medline].
15. De Leo FR, Ulman KV, Davis AR, Jutila KL, Quinn MT. Assembly of the human neutophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 1996;271:17013-17020.
16. Okamura N, Babior BM, Mayo LA, Peveri P, Smith RM, Curnutte JT. The p67-phox cytosolic peptide of the respiratory burst oxidase from human neutrophils. Functional aspects. J Clin Invest 1990; 85: 1583-1587 .
17.
Ushio-Fukai M,
Zafari AM,
Fukui T,
Ishizaka N,
Griendling KK.
p22phox
is a critical component of the superoxide-generating NADH/NADPH
oxidase system and regulates angiotensin II-induced hypertrophy in
vascular smoth muscle cells.
J Biol Chem
1996;
271:
23317-23321
18.
Bayrakutan U,
Draper N,
Lang D,
Shah AJ.
Expression of a functional
neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells.
Cardiovasc Res
1998;
38:
256-262
19. Liochev SI, Fridovich I. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys 1997; 337: 115-120 [Medline].
20.
Li Y,
Zhu H,
Kuppusamy P,
Roubaud V,
Zweier JL,
Trush MA.
Validation of lucigenin (bis-N-methylacridinium) as a chemiluminescence
probe for detecting superoxide anion radical production by enzymatic
and cellular systems.
J Biol Chem
1998;
273:
2015-2023
21.
Berry C,
Hamilton CA,
Brosnan J,
Magill FG,
Berg GA,
McMurray JV,
Dominiczak AF.
Investigation into the sources of superoxide in human blood vessels. Angiotensin II increases superoxide production in
human internal mammary arteries.
Circulation
2000;
101:
2206-2212
22.
Görlach A,
Brandes RP,
Nguyen K,
Amidi M,
Dehghani F,
Busse R.
A
gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall.
Circ Res
2000;
87:
26-32
23. Zulueta JJ, Yu FS, Hertig IA, Thannickal VJ, Hassoun PM. Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol 1995; 12: 41-49 [Abstract].
24.
Zafari AM,
Ushio-Fukai M,
Akers M,
Yin Q,
Shah A,
Harrison D,
Taylor WR,
Griendling KK.
Role of NADH/NADPH oxidase-derived
H2O2 in angiotensin II-induced vascular hypertrophy.
Hypertension
1998;
32:
488-495
25. Sankarapandi S, Zweier JL, Mukherjee G, Quinn MT, Huso DL. Measurement and characterization of superoxide generation in microglial cells: evidence of an NADPH oxidase-dependent pathway. Arch Biochem Biophys 1998; 353: 312-321 [Medline].
26. Li Y, Stansbury KH, Zhu H, Trush MA. Biochemical characterization of lucigenin (bis-N-methylacridinium) as a chemiluminescent probe for detecting intramitochondrial superoxide anion radical production. Biochem Biophys Res Commun 1990; 262: 80-87 .
27. Llesuy S, Evelson P, Gonzalez-Flecha B, Peralta J, Carreras MC, Poderoso JJ, Boverism A. Oxidative stress in muscle and liver of rats with septic syndrome. Free Radic Biol Med 1994; 16: 445-451 [Medline].
28. Supinski GS, Nethery D, DiMarco A. Endotoxin induces free radical mediated diaphragm and intercostal muscle dysfunction. Am Rev Respir Dis 1998; 148: 1318-1324 .
29.
Nethery D,
DiMarco A,
Stofan D,
Supinski G.
Sepsis increases contraction-related generation of reactive oxygen species in the diaphragm.
J
Appl Physiol
1999;
87:
1279-1286
30.
Brandes RP,
Koddenberg G,
Gwinner W,
Kim DY,
Kruse HJ,
Busse R,
Mugge A.
Role of increased production of superoxide anions by
NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia.
Hypertension
1999;
33:
1243-1249
31.
De Keulenaer GW,
Alexander RW,
Ushio-Fukai M,
Ishizaka N,
Griendling KK.
Tumour necrosis factor
activates p22phox-based NADH oxidase
in vascular smooth muscle.
Biochem J
1998;
329:
653-657
.
32.
Hussain SNA,
Giaid A,
El-Dwairi Q,
Sakkal D,
Hattori R,
Guo Y.
Expression of nitric oxide synthase isoforms and GTP cyclohydrolase I in
the ventilatory and limb muscles during endotoxemia.
Am J Respir
Cell Mol Biol
1997;
17:
173-180
33. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the Good, the Bad, and the Ugly. Am J Physiol 1996; 271: c1424-c1437 .
34.
Wang HD,
Pagano PJ,
Du Y,
Cayatte AJ,
Quinn MT,
Brecher P,
Cohen RA.
Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide.
Circ Res
1998;
82:
810-818
35.
Comtois A,
El-Dwairi Q,
Laubach VE,
Hussain SNA.
Lipopolysaccharide-induced diaphragmatic contractile dysfunction in mice lacking
the inducible nitric oxide synthase.
Am J Respir Crit Care Med
1999;
159:
1975-1980
This article has been cited by other articles:
![]() |
G. Lastra, A. Whaley-Connell, C. Manrique, J. Habibi, A. A. Gutweiler, L. Appesh, M. R. Hayden, Y. Wei, C. Ferrario, and J. R. Sowers Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E110 - E116. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. G. DeMarco, J. Habibi, A. T. Whaley-Connell, R. I. Schneider, R. L. Heller, J. P. Bosanquet, M. R. Hayden, K. Delcour, S. A. Cooper, B. T. Andresen, et al. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2659 - H2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Ferreira and M. B. Reid Muscle-derived ROS and thiol regulation in muscle fatigue J Appl Physiol, March 1, 2008; 104(3): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Allen, G. D. Lamb, and H. Westerblad Skeletal Muscle Fatigue: Cellular Mechanisms Physiol Rev, January 1, 2008; 88(1): 287 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Supinski and L. A. Callahan Free radical-mediated skeletal muscle dysfunction in inflammatory conditions J Appl Physiol, May 1, 2007; 102(5): 2056 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Jackson, D. Pye, and J. Palomero The production of reactive oxygen and nitrogen species by skeletal muscle J Appl Physiol, April 1, 2007; 102(4): 1664 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vassilakopoulos and S. N. A. Hussain Ventilatory muscle activation and inflammation: cytokines, reactive oxygen species, and nitric oxide J Appl Physiol, April 1, 2007; 102(4): 1687 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Van Gammeren, D. J. Falk, M. A. Deering, K. C. DeRuisseau, and S. K. Powers Diaphragmatic nitric oxide synthase is not induced during mechanical ventilation J Appl Physiol, January 1, 2007; 102(1): 157 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, J. R. Sowers, R. Nistala, H. Gong, G. M.-E. Uptergrove, S. E. Clark, E. M. Morris, N. Szary, C. Manrique, and C. S. Stump Angiotensin II-induced NADPH Oxidase Activation Impairs Insulin Signaling in Skeletal Muscle Cells J. Biol. Chem., November 17, 2006; 281(46): 35137 - 35146. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhao, S. A. Swanson, J. Ye, X. Li, J. M. Shelton, W. Zhang, and G. D. Thomas Reactive Oxygen Species Impair Sympathetic Vasoregulation in Skeletal Muscle in Angiotensin II-Dependent Hypertension Hypertension, October 1, 2006; 48(4): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hidalgo, G. Sanchez, G. Barrientos, and P. Aracena-Parks A Transverse Tubule NADPH Oxidase Activity Stimulates Calcium Release from Isolated Triads via Ryanodine Receptor Type 1 S -Glutathionylation J. Biol. Chem., September 8, 2006; 281(36): 26473 - 26482. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Supinski and L. A. Callahan Polyethylene Glycol-Superoxide Dismutase Prevents Endotoxin-induced Cardiac Dysfunction Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mata-Greenwood, A. Grobe, S. Kumar, Y. Noskina, and S. M. Black Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-{beta}1 and reactive oxygen species: a requirement for NAD(P)H oxidase Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L288 - L289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Powers, A. N. Kavazis, and K. C. DeRuisseau Mechanisms of disuse muscle atrophy: role of oxidative stress Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R337 - R344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Blendea, D. Jacobs, C. S. Stump, S. I. McFarlane, C. Ogrin, G. Bahtyiar, S. Stas, P. Kumar, Q. Sha, C. M. Ferrario, et al. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E353 - E359. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barreiro, J. Gea, M. Di Falco, L. Kriazhev, S. James, and S. N. A. Hussain Protein Carbonyl Formation in the Diaphragm Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 9 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Toyoda, T. Hayashi, L. Miyamoto, S. Yonemitsu, M. Nakano, S. Tanaka, K. Ebihara, H. Masuzaki, K. Hosoda, G. Inoue, et al. Possible involvement of the {alpha}1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E166 - E173. [Abstract] [Full Text] [PDF] |
||||
![]() |
|